Self-compassion and self-efficacy in Parkinson’s disease and physical disability
Official title: "Associations of Self-Compassion and Self-Efficacy With Symptom Severity, Functional Status, and Quality of Life in Individuals With Parkinson's Disease: A Cross-Sectional Study"
Run by Acibadem University · NCT07488351 · Data updated 2026-11-12
Researchers will see if higher self-compassion and self-efficacy relate to fewer symptoms, better function, and improved quality of life in people with Parkinson’s disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Acibadem University Academic / other |
| Locations | 1 site (Istanbul, Turkey) |
| Status | Recruiting |
| Started | March 30, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | March 30, 2027 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT07488351 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–85 with a clinical diagnosis of Parkinson’s disease, Hoehn and Yahr stages 1–3, MMSE ≥24, able to consent and complete questionnaires, attending the movement disorders clinic at Acibadem University.
✕Probably not a fit
Individuals with advanced dementia, major depressive or psychotic disorders, uncontrolled medical conditions, severe sensory impairments, or inability to cooperate with assessments may not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study examines how patients’ self-compassion and belief in their own abilities correlate with symptom severity, daily functioning, and overall quality of life in Parkinson’s disease. Participants will complete self-report questionnaires to measure these psychosocial factors and standard assessments to gauge motor and non-motor symptoms. The study will analyze relationships between these factors in patients at Hoehn and Yahr stages 1–3, aged 40–85, with preserved cognitive function. Data collection occurs in a movement disorders outpatient clinic setting at Acibadem University in Istanbul. No experimental intervention is involved beyond questionnaires, and results may inform supportive strategies for managing Parkinson’s disease.
Why it matters
Potential benefit: If associations are found, it could help guide psychosocial support strategies to improve quality of life for people with Parkinson’s disease.
How similar studies have gone: Previous research in Parkinson’s has linked psychosocial factors to quality of life, but this exact self-compassion/self-efficacy focus in this population is relatively novel and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of Parkinson's disease * Hoehn and Yahr stage 1-3 * Age 40 to 85 years * Mini-Mental State Examination (MMSE) score ≥24 * Sufficient cognitive function to communicate and complete study assessments * Attending the Movement Disorders Outpatient Clinic, Department of Neurology * Able and willing to provide written informed consent Exclusion Criteria: * Major depressive disorder or psychotic disorder * Advanced dementia * Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension) * Severe cardiovascular or respiratory disease * Additional neurological or orthopedic conditions that may affect assessment performance * Severe visual or hearing impairment that could interfere with study assessments * Inability to cooperate with the physiotherapist during study assessments
Where it's running
-
Acibadem University
Istanbul, Turkey, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Nuray ALACA
- Email: nuray.alaca@acibadem.edu.tr
- Phone: 05324251290
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-guided postural rehabilitation for Parkinson's-related Pisa syndrome and camptocormia
This project tests an AI-guided home rehabilitation program to improve posture for people with Parkinson's disease who have Pisa syndrome or camptocormia.
-
Effects of physical activity on neuroinflammation in Parkinson's disease
This study is testing if being physically active can help reduce inflammation in the brains of people with Parkinson's disease.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.